Oral fluid is an alternative biological matrix that might have advantages over urine for drug analysis in treatment programs. A liquid chromatography-tandem mass spectrometry (LC-MS-MS) method has been used for screening 32 of the most commonly abused drugs and their metabolites in 0.5 mL preserved oral fluid, and the results were compared to results obtained from urine samples taken at the same time. In all, 164 pairs of oral fluid and urine were obtained from 45 patients stabilized on either methadone or buprenorphine. The total number of detections of drugs other than buprenorphine or methadone was 535 in oral fluid and 629 in urine. Morphine was found more often in urine (n = 66) than in oral fluid (n = 48), whereas the opposite was the case for 6-monoacetylmorphine (n = 20 in urine and n = 48 in oral fluid). Methadone showed the same detection frequency in urine and oral fluid (n = 75), whereas amphetamine (n = 45 in urine and n = 51 in oral fluid), methamphetamine (n = 39 in urine and n = 45 in oral fluid), and N-desmethyldiazepam (n = 37 in urine and n = 51 in oral fluid) were detected slightly more often in oral fluid. The other benzodiazepines, cannabis and cocaine were found more frequently in urine samples. If using a sensitive LC-MS-MS technique, oral fluid might be a good alternative to urine for detection of relatively recent use of drugs.
Introduction
Urine is the body fluid most commonly collected for drugtesting programs, but the use of other types of biological specimens has accelerated over the last decade (1) . An advantage with urine samples might be that drug ingestion can be detected for several days, and even weeks later, mainly because of detection of drug metabolites (2) (3) (4) . However, urine may be difficult to collect; supervision intrudes on donors' privacy; the detection of drugs might be affected by, for example, the dilution of the urine due to fluid intake prior to urine sampling; and adulteration of the urine might render the analytical results worthless. Thus, there has been a growing interest in the use of oral fluid as an alternative to urine, and major technological advances have been made, particularly over the last 10 years (1). Collection of oral fluid is inoffensive, rapid, noninvasive, and easy, and the risk of adulteration is considered to be lower (5) . Because of improved analytical techniques with increased sensitivity, a large number of drugs can be analyzed simultaneously in small sample volumes (6) .
Oral fluid is a mixture of saliva, gingival crevicular fluid, cellular debris, and other components (5) . Healthy adult subjects normally produce 500-1500 mL of oral fluid per day, at a rate of approximately 0.5 mL/min, but several physiological and pathological conditions can modify oral fluid production quantitatively and qualitatively (e.g., smell, taste stimulation, chewing, psychological and hormonal status, drugs, age, hereditary influences, oral hygiene, and physical exercise) (7) . The circumstances of the collection can affect production of oral fluid, with higher pH values occurring upon increased stimulation and oral fluid flow. Oral fluid pH typically ranges from 6.2 to 7.4. Drugs that are basic in nature (e.g., amphetamines and opiates) are generally present at higher concentrations in oral fluid than in blood, whereas acidic drugs (e.g. benzodiazepines) are present at lower concentrations (8) .
Compared to urine or hair, a positive result in oral fluid can be interpreted with greater confidence as being attributable to recent drug use, generally within 24 h, and not the consequence of drug intake that has occurred days or weeks earlier.
The detection window in oral fluid is considered to be more like that of blood (9) . The overlap between detection times in oral fluid and urine can, however, be improved by using sensitive methods for oral fluid analysis. The detection window for drugs in oral fluid after repeated ingestion of high doses of drugs of abuse is not well studied (10) . Some studies have compared detection time of drugs of abuse in oral fluid and urine, but the oral fluid and urine were not collected at the same time, and the results from different sample donor groups were also reported (11) . Other studies have compared oral fluid and urine collected at the same time, but analysis for at least one medium was only performed by immunological assay, or few drugs of abuse were included in the analytical program (12) (13) (14) (15) (16) .
Several studies report the use of oral fluid for the detection of illicit drugs, and commercial devices are available (1, 17) . Illicit drugs have been the main focus (5, 15) , but the abuse of legally prescribed drugs such as benzodiazepines, z-hypnotics, methadone, and buprenorphine is common and the ability to monitor it is important as well. A method published by our institute, using liquid chromatography-tandem mass spectrometry (LC-MS-MS), allowed a rapid and sensitive screening for 32 commonly abused drugs and metabolites from 0.5 mL preserved oral fluid (6) . There was good qualitative correspondence between findings in whole blood and oral fluid. Recently, other multicomponent LC-MS-MS methods for detection of illicit and medicinal drugs and metabolites have been published (18, 19) , and this technique is proving to be a valuable tool for oral fluid analysis.
The aim of this study was to investigate whether oral fluid can be an alternative to urine to monitor drug abuse in opioid dependent patients in methadone or buprenorphine treatment programs. To our knowledge, this is the first study that investigates a large number of different drugs of abuse and metabolites (n = 32) in oral fluid by LC-MS-MS in real life samples from patients attending a drug-maintenance program and compares the results to urine samples taken at the same time.
Materials and Methods

Participants
Forty-five opioid-dependent subjects attending a drug-treatment program were included in this study. The patients were treated with methadone or buprenorphine. All the urine samples were collected as part of the drug treatment program. The regional ethics committee approved the collection of oral fluid samples in addition to urine sampling. The results from the oral fluid testing did not have any consequences for the patient, and the regular treatment program was not altered. The extra trouble for the patient was considered minimal. Before its start, a selected group of patients in the drug maintenance program was informed about this study and asked if they were willing to participate. The majority wanted to participate, and signed informed consents were collected. The study was anonymous, and each patient was provided with a unique number. Only one person knew which name and number were connected, and this information was kept confidential.
Sample collection
A total of 164 samples pairs of urine and oral fluid were collected from the 45 subjects between October 1, 2007, and November 8, 2007 , and in the period June 16, 2008 , to August 25, 2008 . A commercially available collecting device (Intercept ® Oral Specimen Collection Device, OraSure Technologies, Bethlehem, PA) that consisted of a cotton pad on a stick was placed in the mouth for 2 min. The collector pad is treated with sodium chloride, citric acid, sodium benzoate, potassium sorbate, gelatine, sodium hydroxide, and deionized water and stimulates oral fluid production. This can have an impact on the measured results (20, 21) . The pad collects a mixture of saliva, gingival crevicular fluid, and mucosal transudate. After sampling, the pad was placed into a vial containing 0.8 mL of stabilizing buffer solution and stored at 4°C until analysis. The preservative contains chlorhexidine digluconate, Flag Blue dye, Tween 20 (nonionic surfactant), and deionized water. The oral fluid samples were collected at the same time as the urine sample. Urine was sampled in vials without additives and stored at 4°C until processing.
Analysis
In the laboratory, the oral fluid samples were analyzed according to the method previously published by Øiestad et al. (6) . Urine samples were screened for amphetamines (EMIT dau reagents from Siemens, SYVA), barbiturates, cannabis, cocaine, methadone, opiates (EMIT II Plus reagents from Siemens, SYVA), LSD, buprenorphine, and benzodiazepines (CEDIA reagents from Thermofisher, Microgenics) by immunological methods using Hitachi 917. pH and creatinine were measured.
Confirmation analyses in urine were performed using LC-MS-MS for benzodiazepines (22) and buprenorphine (23) . Ultra-performance liquid chromatography (UPLC)-MS-MS was used for opiates and cocaine (24) . LSD was extracted using Waters Oasis MCX-extraction columns (3-mL cartridges, 60 mg) and analyzed with UPLC-MS-MS using an Aquity BEH-C18 column (2.1 × 50 mm, 1.7-µm particles). Gradient elution with 5 mM ammonium bicarbonate, pH 10.2, and methanol was used. Amphetamines were analyzed by a gas chromatography (GC)-MS method modified from a whole blood method (25) and includes basic liquid-liquid extraction with cyclohexane followed by derivatization by pentadecafluorooctanoyl chloride (PFOC) and GC-MS analysis. For THC-COOH analysis, the urine samples were hydrolyzed at 60°C in basic solution followed by liquid-liquid extraction with hexane/ethyl acetate Methadone, carisoprodol, and meprobamate were analyzed by LC-MS using a Waters Xterra C18 column (2.1 × 50 mm, 3.5-µm particles) and gradient elution with 5 mM ammonium acetate, pH 5, and acetonitrile. For methadone, the samples were diluted with acetonitrile/ammonium acetate (35:65) before direct injection, whereas for carisoprodol and meprobamate, a protein precipitation with a mixture of cold acetonitrile/ammonium acetate (30:70) was performed, and an aliquot of the acetonitrile supernatant was injected.
Zopiclone was hydrolyzed by treatment with β-glucronidase (approx. 4500 units) at 60°C and extracted using Waters Oasis MCX-extraction columns (3-mL cartridges, 60 mg). LC-MS-MS analysis were performed with a Waters Symmetry C18-column (2.1 × 100 mm, 3.5-µm particles) with gradient elution using 5 mM ammonium acetate, pH 5, and acetonitrile.
The confirmation analyses in urine were only performed if screening analyses in urine were positive. Zopiclone, zolpidem, carisoprodol, and meprobamate were not included in the urine screening and were analyzed only if the oral fluid samples tested positive for these compounds.
Cutoff limits for oral fluid and urine are reported in Table I . The oral fluid analysis is performed on preserved oral fluid from the sampling set, which represents a dilution with a factor of three. The reported concentrations in Table I are therefore corrected to give the direct concentration in oral fluid, and not the preserved oral fluid analyzed.
Results
In all, 164 pairs of saliva and urine samples were obtained from a total of 45 patients. The total number of drugs detected, other than buprenorphine or methadone, was 535 in oral fluid and 629 in urine. Because all patients included in this study were being treated with either buprenorphine or methadone, it was expected that one of these drugs would be detected in each sample. In 134 of the oral fluid/urine pairs, drugs other than buprenorphine or methadone were detected in both oral fluid and urine. Two oral fluid samples contained no drugs, but all urine samples contained one or more drugs. The two negative oral fluid samples were from different patients, but in the corresponding urine samples, buprenorphine and oxazepam were detected in both. In oral fluid, 85% of the samples contained drugs other than buprenorphine or methadone, and 86% of the urine samples. The results from oral fluid and urine are shown in Table II . The mean number of samples collected from each patient was 4 and the range was 1-9. Specificity and sensitivity for detection of drugs in oral fluid are reported in Table III, compared to the urine results. MDMA, MDA, MDEA, zolpidem, fenazepam, bromazepam, lorazepam, barbiturates, LSD, meprobamate, and carisoprodol were not detected in any of the samples.
Because of analytical problems with the buprenorphine analysis, not all buprenorphine results were completed. 
Discussion
In this study, oral fluid was used in addition to simultaneously collected urine to monitor drug abuse among patients admitted to a drug-maintenance program. For most of the drugs tested there were similar findings obtained for oral fluid and urine. Some important differences were, however, observed between the two matrices. Sensitive LC-MS-MS analysis of oral fluid was used to achieve better correlation with common detection times in urine. The cutoff for oral fluid is, however, substantially lower compared to urine. Use of amphetamine or methamphetamine, and particularly heroin [as 6-monoacetylmorphine (6-MAM)], was more commonly detected in oral fluid samples than urine. Cannabis and benzodiazepine intake were more commonly detected in urine samples, as expected from previous studies. This was not seen for N-desmethyldiazepam, a metabolite of diazepam, which was detected in substantially more oral fluid samples.
To be able to compare the detection of drugs of abuse in oral fluid with the traditional urine samples, a selected group of the patients treated with methadone or buprenorphine with known abuse of non-prescribed drugs and narcotics was included in this study. The number of positive samples can thus not be used as a measure for the general results of maintenance treatment with buprenorphine or methadone in Norway.
Opioids
The patients attending the drug treatment program in this study had a history of drug abuse, in particular of opiates. * Sensitivity = (n detected in both urine and oral fluid)/(n detected in both urine and oral fluid + n detected in urine but not oral fluid) Specificity = (n not detected in urine or oral fluid)/(n not detected in urine or oral fluid + n detected in oral fluid but not urine). † There were analytical problems with this compound. ‡ Cocaine was not detected in both urine and oral fluid in any of the sample pairs. Detection of opiates like heroin are thus of special importance when a testing procedure is chosen. After intake, heroin is metabolized within a few minutes to 6-MAM and then further to morphine (26) . 6-MAM is regularly used as a marker for heroin intake, but its short half-life makes it only detectable for a few hours, and morphine and codeine are most frequently detected in urine (4, 26) . It is, however, difficult to differentiate heroin use from morphine or codeine ingestion by urine samples because morphine and/or codeine are often the only substances that are detected. The concentrations of these drugs and the ratio between the concentrations might only suggest heroin ingestion and are often not conclusive (4) . In this study, morphine was detected in both oral fluid and urine from 45 patients and also in oral fluid from 3 and urine from 21 participants (Table IV) . The opposite was seen for 6-MAM, which was detected in 48 of the oral fluid samples, 20 urine samples, and in both matrices in 19 cases. Other studies have also reported the advantages of using oral fluid for revealing heroin ingestion and the advantages over serum regarding detection of 6-MAM (17, 27) . 6-MAM is reported to be detectable in oral fluid specimens containing both high and low morphine concentrations (26) . As most patients in methadone and buprenorphine assisted rehabilitation programs are former heroin abusers, the possible superiority of oral fluid 6-MAM detection in verifying relapse to heroin use may be important.
Cannabis
Cannabis is the most commonly used illegal drug in most countries (29) , and there is a demand for drug testing devices. The inactive metabolite 11-nor-∆ 9 -tetrahydrocannabinol-9-carboxylic acid (THCCOOH) is frequently detected in urine, and the psychoactive ∆ 9 -tetrahydrocannabinol (THC) can be detected in oral fluid. The presence of THC in oral fluid can generally be regarded as evidence of recent cannabis use, whereas detection of THC-COOH in urine may be due to either recent use or to accumulation from long-term use (3). For cannabis, the primary route of drug entry into oral fluid appears to be direct deposition from smoking (30); different studies draw very different conclusions, from a physiological link between oral fluid and plasma (10) to incidental correspondence between oral fluid and serum (31) . The metabolite THCCOOH has also been detected in oral fluid (32) .
Our study revealed that a total of 99 urine samples contained THCCOOH, and THC was detected in oral fluid in 82 samples. The long detection time of THCCOOH in urine, especially after chronic cannabis ingestion, can, however, lead to several positive serial urine samples that actually represent the same ingestion (3). THC was successfully detected in oral fluid in a considerable proportion of the samples in this study, and if detection of recent cannabis intake is the main issue, oral fluid might be preferable to urine as a sample matrix.
Benzodiazepines
Benzodiazepines are frequently prescribed, but also abused (33), and it is therefore important to be able to detect them in a drug screening program. Benzodiazepines and their active metabolites bind to plasma proteins, and the concentration in oral fluid is reported to be low (34) . Diazepam is metabolized in the body to N-desmethyldiazepam, 3-OH-diazepam, and oxazepam (35) . Of these metabolites, oxazepam is the only one that is prescribed as a parent drug in Norway, and 3-OH-diazepam and/or Ndesmethyldiazepam are mainly considered to be metabolites of diazepam. 3-OH-Diazepam and oxazepam were detected in fewer oral fluid samples compared to urine, whereas N-desmethyldiazepam was detected in more oral fluid samples. In Norway, diazepam is a more popular drug of abuse than oxazepam (33) , which is probably because oxazepam has a delayed absorption and onset of effects (35) that reduces euphoria. Our results show that diazepam abuse might be just as well monitored in oral fluid as in urine (Table V) . The detection power for use of oxazepam is, however, inferior in oral fluid. The 7-nitro-1.4-benzodiazepines (flunitrazepam, clonazepam, and nitrazepam) were detected in several of the samples. 7-Aminoflunitrazepam was detected in 81 samples, 7-aminoclonazepam in 42, and 7-aminonitrazepam in 15 oral fluid and/or urine samples. All three drugs were detected in fewer oral fluid samples compared to urine, as expected due to their low concentration (34) . Urine thus has advantages over oral fluid concerning detection of all the 7-nitro-1.4-benzodiazepines.
Z-Hypnotics (zopiclone and zolpidem)
The prescription of z-hypnotics, mainly zopiclone, has increased in Norway over the last decade (36) . Only five samples were positive for zopiclone in this study, four in both matrixes and one in oral fluid only. Zopiclone was not included in the urine screening, and urine samples were analyzed only if the oral fluid was positive. The urine results might thus be too low. Zolpidem was not detected in either oral fluid or urine.
Amphetamine and methamphetamine
Both amphetamine and methamphetamine are basic drugs. They are excreted into oral fluid and trapped because of the lower pH in comparison to blood, leading to higher concentrations than in serum (27) . Detection time for amphetamine and methamphethamine is reported to be much shorter for oral fluid than urine (10), but there are not many reports, and the oral fluid results are compared to urine collected in different studies (11). Schepers et al. (37) investigated the pharmacokinetics of methamphetamine and amphetamine in oral fluid and plasma after single and repeated administration of therapeutic doses (10 and 20 mg) of sustained-release tablets of methamphetamine. They revealed that methamphetamine might be detected in oral fluid for 72 h, but later samples were not collected (37) . Twenty milligrams is considered to be a low dose compared to doses seen in drug abusers. Central nervous system stimulant drugs might lead to dry mouth and analytical problems due to small sample volume of oral fluid (10, 38) . This was, however, not a problem in this study because even though the sample volume was low in some of the samples containing amphetamine and/or methamphetamine, the drug concentrations in these samples were very high. This study shows that both amphetamine and methamphetamine are detectable in oral fluid, for a comparable or possibly longer time than in urine, using the applied methods.
Cocaine and benzoylecgonine (BE)
Several reports have described the detection of cocaine in oral fluid (39, 40) . Although it is expected that cocaine would be rapidly excreted in oral fluid, the amount excreted is highly pHdependent. Stimulation of oral fluid to near maximum rates with citric acid candies substantially reduced the concentrations of cocaine and metabolites in oral fluid (39) . Our study showed that cocaine was only detected in three samples, two in oral fluid alone and one in urine alone. The number of samples containing cocaine is thus too small to allow conclusions.
BE is a metabolite of cocaine that is frequently analyzed to detect ingestion of cocaine because of its longer elimination time in urine (41) . The detection of BE in oral fluid was first reported by Schramm et al. (42) . The pK a for BE is less than 5.5, and the oral fluid concentration is not pH-dependent (39) . In our study, BE was detected in oral fluid and urine from one patient and also in five urine samples where the results in oral fluid were negative. The total number of positive BE samples in this study is too low to be able to conclude which matrix that is most suitable.
Matrix
When drug testing is performed, it is important to critically evaluate which matrix might have the most advantages for the population that is tested. Overall, drugs can be detected for a longer period in urine (9) , and urine has been the main matrix for drug testing for decades (5, 43) . Collection of urine can, however, be time consuming, and supervision demands special facilities and might be considered an intrusion upon patients' privacy. Dilution of the urine by fluid intake prior to testing might affect drug concentrations.
Oral fluid can easily be obtained through non-invasive methods and under supervision without intrusion of privacy (39) . For medical doctors, the oral fluid samples make it possible to collect samples during the consultation (e.g., in the office) without the need for extra facilities. Complicating factors include lower drug concentrations in oral fluid for some drug groups, but application of a more sensitive LC-MS-MS technique might solve this problem (6) . The low protein content of oral fluid (0.3%) also has analytical advantages because there is less interference from endogenous components (8) ; however, the inclusion of surfactants and other additives in commercial sample collection kits represent other analytical challenges. Detection of drugs in oral fluid might be due to contamination with drug residues after oral administration, smoking or snorting. Under extreme exposure to cannabis smoking, the oral fluid specimens collected in the presence of cannabis smoke might be contaminated, but the risk of a positive test for THC has been reported to be eliminated when specimens are collected in the absence of THC smoke (44) . A disadvantage of using oral fluid is the variable nature regarding pH and the influence of collection devices and procedures on drug concentrations.
Conclusions
Drug-testing is commonly performed, and from our results, oral fluid should be considered a suitable matrix, with rapid and non-invasive sampling as the biggest advantages. As expected, more of the urine samples tested positive for drugs other than buprenorphine or methadone compared to oral fluid (15% fewer detected in oral fluid), but for a substantial part of the oral fluid/urine pairs, the results were in concordance. The sensitive LC-MS-MS technique makes oral fluid an alternative matrix for drug monitoring, compared to urine. Whether these conclusions would also apply to drug users after less frequent drug intakes than the present population remains to be seen.
